RetinalGenix Technologies Welcomes Dr. Taimour Langaee as Advisor for DNA GPS Pharmacogenetics Initiatives
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 13 2025
0mins
Source: Yahoo Finance
Appointment of Dr. Taimour Langaee: RetinalGenix Technologies has appointed Dr. Taimour Langaee as a scientific advisor to enhance its DNA GPS Pharmacogenetics initiatives, aimed at optimizing personalized treatment pathways for retinal and systemic diseases through advanced genetic analysis and imaging.
Integration of Technology in Healthcare: The company is focused on integrating pharmacogenetics, high-resolution retinal imaging, and AI-powered analysis to detect early signs of chronic diseases, improve patient outcomes, and personalize treatment plans based on individual genetic profiles.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like undefined with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
